
Moxilink C 625mg Tablet
Marketer
Lincoln Pharmaceuticals Ltd
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Overview Moxilink C 625mg Tablet
Cefuroxime axetil 625mg tablets are a bacterial infection fighter. They treat lung (pneumonia, for example), ear, sinus, urinary tract, skin, and soft tissue infections. This medication is ineffective against viral illnesses like the common cold. Taking it with food minimizes stomach discomfort. Follow your doctor's prescribed schedule, taking it consistently at even intervals for optimal effectiveness. Consistent daily timing aids adherence. Dosage varies depending on the infection; always complete the full course, even if you feel better. Premature discontinuation risks bacterial survival, infection recurrence, or worsening. Common side effects include nausea, diarrhea, vomiting, oral or genital yeast infections, rashes, and vaginitis. These are usually mild, but report persistent or bothersome symptoms to your physician. Inform your doctor of any antibiotic allergies, kidney or liver issues, and all other medications you're taking, as interactions are possible. Generally safe for pregnant and breastfeeding individuals under medical supervision.
Uses of Moxilink C 625mg Tablet
Managing bacterial infections
Major Benefits of Moxilink C 625mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Moxilink C 625mg Tablet should be administered with a meal.
Common Side effects of Moxilink C 625mg Tablet:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Moxilink C 625mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Moxilink C 625mg tablets should be administered with food.
How Moxilink C 625mg Tablet works:
Amoxycillin and Clavulanic Acid, combined as Moxilink C 625mg Tablet, offer targeted antibacterial action. Amoxycillin, the antibiotic component, disrupts bacterial cell wall synthesis, hindering bacterial survival. Clavulanic Acid, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Amoxycillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Moxilink C 625mg Tablet and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Cefixime 625mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Amoxicillin/clavulanate potassium 625mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Moxilink C 625mg Tablets, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Amoxicillin/clavulanate 625mg tablets require careful administration for individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Amoxicillin/clavulanate 625mg tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Routine liver function monitoring is recommended during treatment.
What if you forget to take Moxilink C 625mg Tablet :
Should you forget a Moxilink C 625mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Moxilink C 625mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
